+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

EBOS Group Ltd (EBO) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 46 Pages
  • September 2023
  • GlobalData
  • ID: 3978970
EBOS Group Ltd (EBO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

EBOS Group Ltd (EBOS) is a supplier of healthcare products. The company markets, sells, and distributes healthcare, medical and pharmaceutical products. It also markets and distributes animal care products and offers distribution, warehousing and logistics support to pharmaceutical manufacturers and medical device suppliers. The company offers products under various brands such as Symbion, Pro Pharma, Minfos, Master Pet, Vita Pet and Black Hawk, among others. EBOS serves private and public hospitals, general practitioners, aged care facilities, specialist clinics, community centers, pharmacies, professionals, consumers, pet stores, veterinary clinics and manufacturers, among others. It has presence in Australia and New Zealand. EBOS is headquartered in Docklands, Victoria, Australia.

EBOS Group Ltd Key Recent Developments

  • May 01, 2023: Julie Tay appointed as independent director
  • Feb 21, 2023: EBOS announces results for H1 of 2023 financial year
  • Aug 24, 2022: EBOS 2022 Full Year Results
  • Feb 16, 2022: EBOS Reports Another Record Result and Continued Double-Digit Growth

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • EBOS Group Ltd - Key Facts
  • EBOS Group Ltd - Key Employees
  • EBOS Group Ltd - Key Employee Biographies
  • EBOS Group Ltd - Major Products and Services
  • EBOS Group Ltd - History
  • EBOS Group Ltd - Company Statement
  • EBOS Group Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • EBOS Group Ltd - Business Description
  • Business Segment: Animal Care
  • Overview
  • Performance
  • Business Segment: Healthcare
  • Overview
  • Performance
  • Geographical Segment: Australia
  • Performance
  • Geographical Segment: New Zealand
  • Performance
  • EBOS Group Ltd - Corporate Strategy
  • EBOS Group Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • EBOS Group Ltd - Strengths
  • EBOS Group Ltd - Weaknesses
  • EBOS Group Ltd - Opportunities
  • EBOS Group Ltd - Threats
  • EBOS Group Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
  • EBOS Group Ltd, Recent Deals Summary
Section 4 - Company’s Recent Developments
  • May 01, 2023: Julie Tay appointed as independent director
  • Feb 21, 2023: EBOS announces results for H1 of 2023 financial year
  • Aug 24, 2022: EBOS 2022 Full Year Results
  • Feb 16, 2022: EBOS Reports Another Record Result and Continued Double-Digit Growth
  • Feb 08, 2022: EBOS Group: Resignation of director
Section 5 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • EBOS Group Ltd, Key Facts
  • EBOS Group Ltd, Key Employees
  • EBOS Group Ltd, Key Employee Biographies
  • EBOS Group Ltd, Major Products and Services
  • EBOS Group Ltd, History
  • EBOS Group Ltd, Other Locations
  • EBOS Group Ltd, Subsidiaries
  • EBOS Group Ltd, Key Competitors
  • EBOS Group Ltd, Ratios based on current share price
  • EBOS Group Ltd, Annual Ratios
  • EBOS Group Ltd, Interim Ratios
  • EBOS Group Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • EBOS Group Ltd, Performance Chart (2019 - 2023)
  • EBOS Group Ltd, Ratio Charts

Samples

Loading
LOADING...

Companies Mentioned

A selection of companies mentioned in this report includes:

  • CARE Medical Ltd
  • InterMed Medical Ltd
  • InterMed Medical Ltd
  • Advance Diagnostics NZ Ltd
  • CARE Medical Ltd
  • Advance Diagnostics NZ Ltd